Home / Inspections / 1252822

FDA Inspection 1252822 — Navinta, LLC

Navinta, LLC — FEI 3004375014

The FDA completed an inspection of Navinta, LLC on September 30, 2024 in Ewing, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 30, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ewing, NJ (United States)

Facility

Other inspections at this facility

  • 1205480 (NAI Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1084188 (VAI Thu Mar 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022105 (VAI Fri Aug 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 971010 (OAI Mon May 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 937748 (NAI Mon Aug 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources